Journal article
Regulation of FAS Ligand Expression during Activation-Induced Cell Death in T Cells by p38 Mitogen-Activated Protein Kinase and C-Jun Nh2-Terminal Kinase
The Journal of experimental medicine, Vol.191(6), pp.1017-1030
03/20/2000
DOI: 10.1084/jem.191.6.1017
PMCID: PMC2193110
PMID: 10727463
Abstract
Activation-induced cell death (AICD) is a mechanism of peripheral T cell tolerance that depends upon an interaction between Fas and Fas ligand (FasL). Although c-Jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) may be involved in apoptosis in various cell types, the mode of regulation of FasL expression during AICD in T cells by these two MAPKs is incompletely understood. To investigate the regulatory roles of these two MAPKs, we analyzed the kinetics of TCR-induced p38 MAPK and JNK activity and their regulation of FasL expression and AICD. We report that both JNK and p38 MAPK regulate AICD in T cells. Our data suggest a novel model of T cell AICD in which p38 MAPK acts early to initiate FasL expression and the Fas-mediated activation of caspases. Subsequently, caspases stimulate JNK to further upregulate FasL expression. Thus, p38 MAPK and downstream JNK converge to regulate FasL expression at different times after T cell receptor stimulation to elicit maximum AICD.
Details
- Title: Subtitle
- Regulation of FAS Ligand Expression during Activation-Induced Cell Death in T Cells by p38 Mitogen-Activated Protein Kinase and C-Jun Nh2-Terminal Kinase
- Creators
- Jian Zhang - Autoimmunity/Diabetes Group, The John P. Robarts Research Institute, London, Ontario N6G 2V4, CanadaJian-Xin Gao - Autoimmunity/Diabetes Group, The John P. Robarts Research Institute, London, Ontario N6G 2V4, CanadaKostantin Salojin - Autoimmunity/Diabetes Group, The John P. Robarts Research Institute, London, Ontario N6G 2V4, CanadaQing Shao - Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario N6A 5C1, CanadaMarsha Grattan - Autoimmunity/Diabetes Group, The John P. Robarts Research Institute, London, Ontario N6G 2V4, CanadaCraig Meagher - Autoimmunity/Diabetes Group, The John P. Robarts Research Institute, London, Ontario N6G 2V4, Canada, Department of Microbiology and Immunology, University of Western Ontario, London, Ontario N6A 5C1, CanadaDale W Laird - Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario N6A 5C1, CanadaTerry L Delovitch - Autoimmunity/Diabetes Group, The John P. Robarts Research Institute, London, Ontario N6G 2V4, Canada, Department of Microbiology and Immunology, University of Western Ontario, London, Ontario N6A 5C1, Canada, Department of Medicine, University of Western Ontario, London, Ontario N6A 5C1, Canada
- Resource Type
- Journal article
- Publication Details
- The Journal of experimental medicine, Vol.191(6), pp.1017-1030
- DOI
- 10.1084/jem.191.6.1017
- PMID
- 10727463
- PMCID
- PMC2193110
- ISSN
- 0022-1007
- eISSN
- 1540-9538
- Language
- English
- Date published
- 03/20/2000
- Academic Unit
- Pathology
- Record Identifier
- 9984046814302771
Metrics
11 Record Views